Literature DB >> 6129809

Tardive dyskinesia and anticholinergic drugs.

G Gardos, J O Cole.   

Abstract

The evidence from the literature does not support the notion that psychotropic drugs with central anticholinergic properties (antiparkinsonian drugs, neuroleptics, antidepressants) constitute a risk factor in tardive dyskinesia. Antiparkinsonian drugs tend to produce reversible increases in the severity of dyskinetic movements and can be used as pharmacological probes in the assessment of neuroleptic-induced movement disorders.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6129809     DOI： 10.1176/ajp.140.2.200

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


  7 in total

1.  Early dyskinesia--vulnerability.

Authors:  J O Cole; G Gardos; L A Boling; D Marby; D Haskell; P Moore
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 2.  Tardive dyskinesia.

Authors:  T R Barnes
Journal:  Br Med J (Clin Res Ed)       Date:  1988-01-16

Review 3.  Antipsychotic-Induced movement disorders in the elderly: epidemiology and treatment recommendations.

Authors:  M R Caligiuri; D V Jeste; J P Lacro
Journal:  Drugs Aging       Date:  2000-11       Impact factor: 3.923

4.  Treatment Recommendations for Tardive Dyskinesia.

Authors:  Lucia Ricciardi; Tamara Pringsheim; Thomas R E Barnes; Davide Martino; David Gardner; Gary Remington; Donald Addington; Francesca Morgante; Norman Poole; Alan Carson; Mark Edwards
Journal:  Can J Psychiatry       Date:  2019-02-21       Impact factor: 4.356

5.  Persistent catalepsy associated with severe dyskinesias in rats treated with chronic injections of haloperidol decanoate.

Authors:  T M Hyde; M F Egan; L L Wing; R J Wyatt; D R Weinberger; J E Kleinman
Journal:  Psychopharmacology (Berl)       Date:  1995-03       Impact factor: 4.530

6.  The impact of neuroleptic medication on tardive dyskinesia: a meta-analysis of published studies.

Authors:  H Morgenstern; W M Glazer; D Niedzwiecki; P Nourjah
Journal:  Am J Public Health       Date:  1987-06       Impact factor: 9.308

7.  [Antipsychotic-induced motor symptoms in schizophrenic psychoses-Part 3 : Tardive dyskinesia].

Authors:  D Hirjak; K M Kubera; S Bienentreu; P A Thomann; R C Wolf
Journal:  Nervenarzt       Date:  2019-05       Impact factor: 1.214
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.